STRATA Skin Sciences

Yahoo Finance • last year

STRATA Skin Sciences Reports Third Quarter 2023 Revenue

HORSHAM, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • last year

STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023

HORSHAM, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • last year

STRATA Skin Science Announces Leadership Change

Bob Moccia Steps Down as CEO and Member of the Board Dr. Dolev Rafaeli, Named New Vice-Chairman, President and CEO HORSHAM, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company... Full story

Yahoo Finance • last year

STRATA Skin Sciences to Participate in Upcoming Medical Conferences

HORSHAM, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • last year

STRATA Skin Sciences to Present at Upcoming October Conferences

HORSHAM, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditi... Full story

Yahoo Finance • last year

STRATA Skin Sciences to Host Virtual KOL Event on XTRAC® and TheraClear®X

HORSHAM, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • last year

MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update

EscharEx® Phase III study protocol:FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations with wound industry leaders NexoBrid®U.S. commercial launch timing not anticipated toimpact revenues in 2023-202... Full story

Yahoo Finance • last year

STRATA Announces JCAD Publication: Photopneumatic Technology for the Treatment of Mild-to-Moderate Acne Vulgaris

HORSHAM, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • last year

STRATA Skin Sciences Secures additional $12 Million Financing with MidCap Financial

HORSHAM, Pa., July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • last year

STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of Directors

HORSHAM, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditio... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Announces TheraClear®X Product Demonstration at Music City Scale Symposium for Cosmetic Advances and Laser Education

HORSHAM, Pa., May 19, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic condition... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Reports First Quarter 2023 Revenue

Achieved revenue of $7.6 million for the first quarter 2023 Company to host conference call and webcast today, May 15, 2023, at 4:30 PM ET HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a med... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Enters India Market with Exclusive Distribution Agreement with Spectra Medical

STRATA expects to receive regulatory approval in India during December 2023 India has the highest prevalence of vitiligo in the world, at about 8.8%1 HORSHAM, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SS... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences to Report First Quarter 2023 Financial Results on May 15, 2023

HORSHAM, Pa., May 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic condition... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Pre-Announces First Quarter 2023 Results

Preliminary revenue to be within the range of $7.3 - $7.8 million and expected to be the strongest first-quarter results since first quarter of 2016Company exceeds plan with 44 TheraClear®X placements in the first quarter HORSHAM, Pa., Ap... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Reports Record Fourth Quarter 2022 Revenue

Achieved record revenue of $36.2 million, representing 21% increase over the year 2021 Company to host conference call and webcast today, March 31, 2023, at 8:30 AM ET HORSHAM, Pa., March 31, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Scienc... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023

HORSHAM, Pa., March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditi... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023

HORSHAM, Pa., March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditi... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Affirms No Exposure to Silicon Valley Bank

HORSHAM, Pa., March 13, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditi... Full story

Yahoo Finance • 2 years ago

STRATA Skin Sciences Announces the Launch of New, Patient-Focused XTRAC® Website

HORSHAM, Pa., March 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditi... Full story